Combinations ; Candesartan/Hydrochlorothiazide- see below
Dosage ; 16 mg OD initially (max. daily dose 32mg).
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Advant | Getz Pharmaceuticals | Surgipharm Ltd | 8mg | 14 | Tablet | per tablet | KES 719.00 |
| Advant | Getz Pharmaceuticals | Surgipharm Ltd | 16mg | 14 | Tablet | per tablet | KES 1,062.00 |
| ARB-8 | Square Pharmaceuticals Ltd | ACE Pharmaceuticals Ltd | 8mg | 30 | Tablet | per tablet | KES 480.00 |
| ARB-8 | Square Pharmaceuticals Ltd | ACE Pharmaceuticals Ltd | 16mg | 90 | Tablet | per tablet | KES 675.00 |
| Atacand | AstraZeneca | Laborex Kenya Eurapharma Ltd | 8mg | 28 | Tablet | per tablet | KES 2,478.00 |
| Atacand | AstraZeneca | Laborex Kenya Eurapharma Ltd | 16mg | 28 | Tablet | per tablet | KES 3,235.00 |
| Atacand | AstraZeneca | Laborex Kenya Eurapharma Ltd | 32mg | 28 | Tablet | per tablet | KES 3,721.00 |
| Candecard | Sandoz | Phillips Pharmaceuticals Ltd. | 8mg | 28 | Tablet | per tablet | KES 591.00 |
| Candecard | Sandoz | Phillips Pharmaceuticals Ltd. | 16mg | 28 | Tablet | per tablet | KES 1,085.00 |
| Candez | Indswift Limited | Sai Pharmaceuticals Ltd. | 4mg | 10 | Tablet | per tablet | KES 227.00 |
| Candez | Indswift Limited | Sai Pharmaceuticals Ltd. | 8mg | 10 | Tablet | per tablet | KES 350.00 |
| Candez | Indswift Limited | Sai Pharmaceuticals Ltd. | 16mg | 30 | Tablet | per tablet | KES 1,578.00 |
| Treatan | Pharmevo Pharmaceuticals Ltd | Harley's Limited | 8mg | 14 | Tablet | per tablet | KES 597.00 |
| Candesartan More info | |
|---|---|
| Mode Of Action | It blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II by selectively blocking the binding of angiotensin II to the AT1 receptor in a number of tissues. It does not cause persistent dry cough that normally complicates ACE inhibitors therapy. This is due to the fact that it does not inhibit the breakdown of kinins. |
| Drug Indication | Hypertension |
| Precautions | Severe congestive heart failure. |
| Contra-Indications | Pregnancy; allergy to the drug. |
| Side Effects | Hyperuricemia; hypotension, leukopenia; thrombocytopenia; back pain; dizziness; headache; pharyngitis; rhinitis; URTI |
| Dosage | 16 mg OD initially (max. daily dose 32mg). |
| Pregnancy Category | Category C |
| Pregnancy Category Description | Drugs which, owing to their pharmacological effects, or may be suspected of causing detrimental effects on human foetus or neonates without causing malfunctions. These effects may be reversible |
| Drug Category | DRUGS ACTI NG ON THE CARDIO-VASCULAR SYSTEM |
| Drug Sub-Category | Angiotensin (AT1 ) receptor blockers |
Candesartan/Hydrochlorothiazide Brands
| Brand Name | Manufacturer Name | Distributor | Drug Strength | Packaging | Formulation | Formulation Strength | Price |
|---|---|---|---|---|---|---|---|
| Advantec | Getz Pharmaceuticals | Surgipharm Ltd | 16mg/12.5mg | 30 | Tablet | per tablet | KES 2,219 |
| Atacand plus | AstraZeneca | Radiance Pharmaceuticals Limited | 16mg/12.5mg | 28 | Tablet | per tablet | KES 3,235.00 |
| Atacand plus | AstraZeneca | Radiance Pharmaceuticals Limited | 32mg/25mg | 28 | Tablet | per tablet | KES 3,322.00 |
| Candesartan/Hydrochlorthiazide More info | |
|---|---|
| Mode Of Action | It blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II by selectively blocking the binding of angiotensin II to the AT1 receptor in a number of tissues. It does not cause persistent dry cough that normally complicates ACE inhibitors therapy. This is due to the fact that it does not inhibit the breakdown of kinins. it also has anti-diuretic activity |
| Drug Indication | Hypertension |
| Precautions | Severe congestive heart failure. |
| Contra-Indications | Pregnancy; allergy to the drug. |
| Side Effects | Hyperuricemia; hypotension, leukopenia; thrombocytopenia; back pain; dizziness; headache; pharyngitis; rhinitis; URTI |
| Dosage | 1 Once Daily |
| Pregnancy Category | Category C |
| Pregnancy Category Description | Drugs which, owing to their pharmacological effects, or may be suspected of causing detrimental effects on human foetus or neonates without causing malfunctions. These effects may be reversible |
| Drug Category | DRUGS ACTI NG ON THE CARDIO-VASCULAR SYSTEM |
| Drug Sub-Category | Angiotensin (AT1 ) receptor blockers |